Single Nucleus Expression Profiling of Human Sciatic Nerve After Traumatic Amputation: Predicting Pain and Functional Outcomes
Abstract
A majority of service members who undergo traumatic amputation develop chronic phantom or chronic residual limb pain with 10-15 percent of these patients developing severe, disabling, long-term pain. 30-40 percent of traumatic amputees, however, have no clinically significant chronic pain. We believe this dichotomy of outcome is the key to understanding the development of chronic neuropathic pain after nerve injury. Preclinical studies using rodent models have provided some insights into the pathological sequelae of nerve injury, but this knowledge has not resulted in successful translation to the clinic. Recent evidence suggests that interspecies differences are a major barrier to successful translation, since rodent sensory neurons diverge considerably from their human counterparts. Accordingly, in order to better understand the pathological processes that lead to neuropathic pain after nerve injury, it is necessary to comprehensively study injured human nerves. Our colleagues at Walter Reed National Military Medical Center spent three years obtaining sciatic nerve samples from service members undergoing primary amputation revision surgery after suffering traumatic amputation on the battlefield. These unique samples allow, for the first time, study of nerve regeneration and neuroinflammation in humans during the days following traumatic amputation. Utilizing bulk tissue and single nuclei RNA-sequencing and unbiased global proteomics of the distal portion of sciatic nerve collected 1-14 days after initial traumatic amputation, we aim to establish the distinctive transcriptional, protein and glial/immune cell profile of injured sciatic nerve during injury and regeneration.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2021
- Accession Number
- AD1156792
Entities
People
- Thomas Van De Ven
Organizations
- Duke University